Spanish Hemoderivatives Manufacturer Grifols Remains Sharply Depressed, Trading 70% Below 2020 Peak
Grifols’ stock continues to decline, trading roughly 70% below its February 2020 peak, indicating that the support levels are holding only for now.
Grifols’ stock continues to decline, trading roughly 70% below its February 2020 peak, indicating that the support levels are holding only for now.
Analysts consider the three lagging IBEX stocks—Grifols, Solaria and Cellnex—to have significant upside, estimating a double‑digit move toward their target prices.